US Pharma MarketingThe shortage follows Hologic removing certain breast biopsy needles from the market in January.
FDA warns breast biopsy needle shortage to continue into 2027
FDA warns breast biopsy needle shortage to continue into 2027 is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive